Mentioned On
Episode Mentions
Biotech Hangout · May 8, 2026
Episode 182 - May 8, 2026
“EBV cell therapy rejected by FDA under Vinay Prasad; now has opportunity to refile without new data under new leadership”
Biotech Secondary Capital Raises and Market SaturationFDA Regulatory Uncertainty and Commissioner McCary LeadershipM&A Activity in Biotech and Venture Capital Returns
View Analysis